Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients

18Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

Abstract

Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.

Cite

CITATION STYLE

APA

Yang, F., Yue, R., Luo, X., Liu, R., & Huang, X. (2020). Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.543718

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free